Pegasys® in Patients With Myeloproliferative Diseases

Clinical trial NCT00452023 · COMPLETED

Trial details

NCT number: NCT00452023
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Disorders

Start date: 2005-04-07
Primary completion: 2023-05-26
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.